Bio-Solutions has reported the negotiation of a supply agreement for its main product GreenEx with three African Countries. The agreement will include the turn key operation of the spreading of GreenEx on highly infested sites within these countries.
The company said that the management at Bio-Solutions has initiated development activities less than 6 month ago in 3 countries. In a specific country, GreenEx has been regulatory approved to be used in a pilot study to demonstrate efficiency in a specific area highly infested and to confirm previous results obtained in different geographic area and different environmental conditions.
Gilles Chaumillon, president and CEO of Bio-Solutions, said: “During our commercialisation efforts of GreenEx, we have realised that our integrated participative approach in highly infested countries gives Bio-Solutions Corp a significant competitive edge.
‘It is important to mention that the environmental conditions and prevalent factors are area specific and require validation of spreading techniques in order to be adequately deployed. In that respect, due to the country specific project sizes, we need to develop partnership with health authority’s upper management as well as respective government highest level of decision.
“Our intention is to develop long term multiple partnership to allow Bio-Solutions to reach profitability during the first year of operation and thus assure recurrent and significant revenues to the company while helping the fight against Malaria vectors, within these Malaria infested countries,” added Chaumillon.